Abstract:Human tissue factor pathway inhibitor (TFPI) is a native specific inhibitor of extrinsic pathway of coagulation in vivo. As a kind of deletion variant which only contains N-terminus, K1 and K2 of TFPI, TFPI 1-161 is an ideal control molecule in the research of structure and function of TFPI. In this article, we not only investigated the methods of expression and purification, but also detected characteristics of TFPI 1-161. Using plasmid pGEM-3Zf(-)-TFPI as a template, DNA of TFPI 1-161 was obtained by PCR and cloned into plasmid pPIC9K to construct expression plasmid pPIC9K-TFPI 1-161. By force of screening multi-copy transformant and optimizing ferment condition, TFPI 1-161 was highly expressed in Pichia pastoris GS115 for the first time and the final yield after purification was increased more than 20-fold comparing with Saccharomyces cerevisiae. TFPI 1-161 was expressed as two different molecular weight proteins namely TFPI 1-161(24kD) and TFPI 1-161(27kD) because of difference of glycosylation. Their isoelectric points were 4.8 and 4.9 respectively. They were separated according to different isoelectric points using anion-exchange chromatography and had similar activity. Approximately 1.4g TFPI 1-161(24kD) and 1.8g TFPI 1-161(27kD) was obtained from 4-liter fermentation culture after purification by ultrafiltration, gel filtration, anion-exchange chromatography. Their specific activity were up to 12 880u/mg and 12 400u/mg respectively. The rate of recovery of TFPI 1-161 was about 55%. The recombinant TFPI 1-161 had good anticoagulant activity in diluted prothrombin time assay (dPT) and anti-FXa activity in a direct amidolytic assay. The expression and purification system described here provides a cost-effective method for generating large amounts of material for further fundamental and preclinical research of TFPI 1-161.

Expression, Purification and Characterization of Recombinant Targeting Bifunctional Hirudin in Pichia Pastoris

Expression, Purification and Characterization of Recombinant Human Coagulation Factor XIIIa in Pichia Pastoris

[Fermentation, Purification and Identification of Recombinant RGD-Hirudin].

Construction,expression and Characterization of Recombinant Fusion Protein HSA-PTH(1-34) in Pichia Pastoris

Expression and affinity purification of small molecule functional peptide of Hirudin in E. coli

Expression, Purification and Characterization of the Recombinant Hirudin Variant Iii in the Bacillus Subtilis

Construction and Expression of Human Coagulation Factor IX in the Pichia Pastoris

Expression and Purification of Hi-lys Peptide,a Recombinant Relevant to Hirudin

Preparation and Biological Activity Assay of Recombinant Reversible Hirudin

Prokaryotic Expression of SA-hirudin-RGD Fusion Proteinand Identification of Its Anticoagulant and Anti-platelet Aggregation Function

Molecular cloning of hirudin derivative cDNA gene and expression in mammalian cell

Cloning, characterization, and heterologous expression of a candidate Hirudin gene from the salivary gland transcriptome of Hirudo nipponia

Expression, Purification, and Mass Spectrometric Analysis of 15N, 13C-Labeled RGD-hirudin, Expressed in Pichia Pastoris, for NMR Studies.

[High Efficient Expression of Recombinant Human Platelet Factor IV in Pichia Pastoris].

Construction and Expression of Chimeric Antithrombotics with Hirudin and RGD Sequence

High Expression and Characterization of Recombinant Deletion Variant TFPI1 - 161 of Human Tissue Factor Pathway Inhibitor in Pichia Pastoris

Expression and purification of the recombinant human tissue factor in Pichia pastoris

Construction, Expression, and Characterization of Recombinant Hirudin in Escherichia Coli.

Expression and characterization of hydrophobin HGFI fused with the cell-specific peptide TPS in Pichia pastoris.

Synthesis of Hirudin Gene by Recursive PCR and Its Expression and Secretion in Escherichia Coli

Design, Preparation and in Vitro Bioactivity of Mono-PEGylated Recombinant Hirudin